Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT02569567
Other study ID # SMART15
Secondary ID 2015-0782
Status Recruiting
Phase N/A
First received October 5, 2015
Last updated November 14, 2015
Start date November 2015
Est. completion date June 2016

Study information

Verified date October 2015
Source Asan Medical Center
Contact So Yeon Kim, Dr
Phone 82-2-3010-5980
Email sykim.radiology@gmail.com
Is FDA regulated No
Health authority Korea: Ministry of Food and Drug Safety
Study type Observational

Clinical Trial Summary

The aim of this prospective study was to evaluate the applicability and diagnostic performances of Smart-Shear wave(SSW) imaging, in comparison with Transient elastography(TE) for the staging of liver fibrosis using pathologic results as the reference standard.


Recruitment information / eligibility

Status Recruiting
Enrollment 105
Est. completion date June 2016
Est. primary completion date June 2016
Accepts healthy volunteers No
Gender Both
Age group 20 Years to 80 Years
Eligibility Inclusion Criteria:

1. Patients with liver disease: plan to undergo liver surgery

2. Potential liver donors

3. Smart-Shear wave & transient elastography were performed within one month from liver surgery

4. Aged between 20 to 80 years

5. Compliance with scheduled visits, evaluation plans and other study procedures

Exclusion Criteria:

1. Previous history of hepatic surgery

2. Previous history of transarterial chemoembolization

3. Huge or infiltrative tumor in the right lobe of the liver

4. Bile duct dilatation in the right lobe of the liver

5. Older than 80 years

6. The opinion of the investigator would make the patient unsuitable for enrollment

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Procedure:
Smart-Shear Wave(SSW) imaging
All Smart-Shear Wave(SSW) imaging examinations will be performed by one operator. The right lobe of the liver is examined through the intercostal view with the patient lying in a supine or semi-decubitus position with the right arm in maximal abduction. Once the optimal sizes of the regions of interest is chosen, they are fixed for subsequent measurement in each subject. Special attention is paid to avoid any focal lesion, vessels, biliary tracts, or artifacts from nearby lung gas or cardiac movement.
Transient elastography(TE)
Using the M probe in patients with BMI <30 kg/m2. Liver measurement is taken at either the seventh or eighth intercostal space of each subject over the right lobe of the liver. The measuring depth ranges from 2.5 to 6.5 cm below the skin surface. Examinations are performed by a sonographer blinded to S-shear wave elastography, and biological results.

Locations

Country Name City State
Korea, Republic of Asan Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Asan Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Non-inferiority of Smart-Shear Wave(SSW) imaging compared to Transient elastography(TE) in diagnosis for hepatic fibrosis. Applicability rate between Smart-Shear Wave(SSW) and Transient elastography(TE) will be compared to prove non-inferiority.
Applicability rate = {[Total cases- (failure cases + non-reliable measurement cases)]/total case} * 100 (%)
1 year No
Secondary Evaluation of diagnostic accuracy to predict the degree of hepatic fibrosis. Areas under the receiver operating curve (AUROCs) of the two techniques will be compared to estimate the probability of correctly predicting the degree of hepatic fibrosis.
Substantial discordance between US elastography techniques and histologic staging will also be explored. It is defined as a difference in fibrosis stage by at least 2 points.
1 year No
Secondary The correlation between two US elastography techniques The correlation between the two US elastography techniques will be tested using the Spearman's correlation coefficient. 1 year No
Secondary Reliability of Smart-Shear Wave(SSW) comparing diagnostic performance according to the reliable measurement index(RMI) results Reliable measurement index (RMI) is an reliability index that computes the reliability of the calculated stiffness by analyzing the changes in shapes of propagated shear waves. The diagnostic performance of Smart-Shear wave will be assessed by comparing the RMI result. 1 year No
Secondary Precision of Smart-Shear Wave(SSW) Precision of Smart-Shear Wave(SSW) will be assessed using the composite factors, including intraclass correlation coefficients (ICCs), within subject SD(wSD), repeatability coefficient(RC), and within subject CV(wCV). 1 year No
See also
  Status Clinical Trial Phase
Recruiting NCT05479721 - LITMUS Imaging Study
Not yet recruiting NCT05120557 - Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH N/A
Active, not recruiting NCT05473806 - Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 Diabetes Phase 4
Not yet recruiting NCT03222167 - Open-Label Efficacy and Safety Study of the Elbasvir/ Grazoprevir Fixed Dose Combination Patients With Chronic HCV GT1b Phase 3
Active, not recruiting NCT02344680 - Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
Not yet recruiting NCT05567614 - Platelets Indices and Its Role to Predict Liver Fibrosis in Patients With Chronic Hepatitis B Infection
Active, not recruiting NCT05402371 - A Study to Evaluate the Efficacy and Safety of Rencofilstat in Subjects With NASH and Advanced Liver Fibrosis Phase 2
Completed NCT03373396 - Impact of Chlordecone on Active Chronic Hepatitis N/A
Recruiting NCT05855031 - The Liver Care Trial N/A
Completed NCT04493346 - Shear Wave Elastography
Completed NCT04380493 - The Use of the Transient Elastography Paediatric Probe, Compared to the M Probe, Indirect Biomarkers and Histology
Active, not recruiting NCT06315361 - DIAbetes and NAFLD
Not yet recruiting NCT03492879 - Non Invasive Electrical Impedance Technology (EIT) for Diagnosing Liver Diseases Severity N/A
Not yet recruiting NCT06366425 - Screening for Chronic Liver Diseases in General Population N/A
Recruiting NCT04442334 - The European NAFLD Registry
Recruiting NCT05692024 - COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER Phase 1/Phase 2
Completed NCT03659058 - Impact of Ursodeoxycholic Acid, Silymarin, Antioxidants and Colchicine on Fibrosis Regression in HCV After SVR N/A
Recruiting NCT05218538 - Liver Cirrhosis Diagnosis Prioritizing Algorithm Based on Electronic Health Records.
Recruiting NCT06248580 - Find HDV and Determine Its Status in Turkey
Completed NCT04480710 - A Study of CRV431 Dosed Once Daily in NASH Induced F2 and F3 Subjects Phase 2